Dr Reddys Laboratories

1,192.80
-20.65
(-1.70%)
Market Cap (₹ Cr.)
1,01,290
52 Week High
1,421.49
Book Value
1,700
52 Week Low
1,074.00
PE Ratio
18.97
PB Ratio
3.29
PE for Sector
37.21
PB for Sector
3.95
ROE
19.74 %
ROCE
25.18 %
Dividend Yield
3.30 %
EPS
333.59
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
12.36 %
Net Income Growth
23.75 %
Cash Flow Change
-22.83 %
ROE
1.99 %
ROCE
0.45 %
EBITDA Margin (Avg.)
6.10 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
2,776
2,636
2,980
2,450
2,506
2,556
2,691
2,658
2,420
2,139
2,295
2,571
2,565
2,653
2,706
2,825
2,718
2,980
3,523
3,113
2,979
3,889
3,372
3,471
3,432
3,620
3,942
3,543
3,783
4,034
4,998
3,949
4,669
5,671
5,062
4,331
5,318
6,059
6,904
Expenses
1,933
1,862
1,977
2,025
2,375
1,928
2,081
1,928
2,051
1,941
1,941
1,988
2,166
2,043
2,066
2,045
2,209
2,078
2,285
2,288
2,331
2,316
2,529
2,634
2,748
2,872
3,075
2,866
2,999
3,051
3,078
3,223
3,493
3,210
3,210
3,447
3,726
3,888
3,975
EBITDA
843
775
1,003
425
131
628
611
730
369
197
354
583
400
610
639
780
509
902
1,238
825
648
1,573
843
837
685
748
866
677
785
983
1,921
727
1,176
2,461
1,852
884
1,591
2,171
2,929
Operating Profit %
28 %
26 %
32 %
17 %
-0 %
11 %
20 %
25 %
11 %
7 %
14 %
21 %
13 %
22 %
21 %
25 %
16 %
17 %
33 %
25 %
18 %
28 %
24 %
22 %
17 %
16 %
19 %
17 %
17 %
16 %
37 %
17 %
23 %
41 %
33 %
16 %
27 %
33 %
40 %
Depreciation
137
142
159
167
181
173
189
184
190
191
195
198
190
192
191
194
204
197
204
196
192
198
214
212
211
197
207
205
205
222
226
239
237
237
246
246
246
250
260
Interest
19
21
15
14
15
13
12
17
16
16
19
13
14
17
16
16
9
12
12
12
12
14
9
7
17
7
11
8
13
10
2
3
3
5
6
6
6
7
28
Profit Before Tax
688
611
829
244
-65
443
409
529
163
-10
140
372
196
401
433
570
296
693
1,021
618
444
1,362
620
618
457
545
649
464
567
752
1,693
485
937
2,220
1,601
632
1,339
1,914
2,641
Tax
116
118
147
64
62
89
67
103
-77
0
33
60
46
79
94
43
66
153
153
109
69
239
111
111
79
98
116
81
97
136
298
199
232
539
396
157
270
467
703
Net Profit
571
493
683
237
-39
409
313
439
223
-7
101
297
177
329
346
399
203
548
1,365
522
503
950
481
444
312
413
449
341
420
500
1,116
325
672
1,639
1,193
475
1,035
1,417
1,882
EPS in ₹
33.54
28.95
40.02
13.89
-2.26
24.13
18.91
26.49
13.46
-0.44
6.07
17.90
10.65
19.82
20.86
24.08
12.22
33.06
82.36
31.47
30.34
57.31
29.00
26.74
18.78
24.94
27.07
20.55
25.29
30.10
67.25
19.54
40.49
98.66
71.68
28.55
62.14
85.10
113.00

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
16,456
17,585
16,447
17,100
16,248
19,476
21,630
24,496
25,375
30,359
Fixed Assets
3,249
4,438
4,842
4,717
4,683
4,434
5,844
6,151
7,195
7,589
Current Assets
10,403
10,211
8,594
9,039
8,933
10,107
10,944
13,491
13,788
17,816
Capital Work in Progress
488
616
540
675
400
412
901
1,200
924
1,211
Investments
2,102
5,076
3,102
3,637
3,934
5,486
4,649
4,937
7,440
7,321
Other Assets
10,616
7,455
7,963
8,072
7,231
9,145
10,235
12,208
9,815
14,239
Total Liabilities
5,822
5,507
4,847
5,293
3,563
4,284
4,646
6,159
4,901
6,119
Current Liabilities
4,679
4,389
4,258
4,720
3,079
4,181
4,560
6,045
4,440
5,538
Non Current Liabilities
1,143
1,118
589
573
484
103
86
114
461
580
Total Equity
10,634
12,078
11,601
11,808
12,684
15,192
16,984
18,336
20,474
24,241
Reserve & Surplus
10,549
11,993
11,518
11,725
12,601
15,109
16,901
18,253
20,391
24,157
Share Capital
85
85
83
83
83
83
83
83
83
83

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-56
135
-135
54
-8
-74
1,266
-146
-1,047
89
Investing Activities
-2,031
-1,919
1,430
-1,180
-546
-1,689
-1,454
-1,990
-3,403
-3,429
Operating Activities
1,786
2,747
1,016
1,539
2,762
1,839
3,514
1,339
5,053
3,450
Financing Activities
189
-693
-2,582
-304
-2,223
-224
-794
506
-2,697
68

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
26.74 %
26.73 %
26.72 %
26.72 %
26.72 %
26.71 %
26.71 %
26.70 %
26.70 %
26.69 %
26.66 %
26.65 %
26.65 %
26.65 %
26.64 %
FIIs
29.03 %
29.04 %
27.76 %
27.42 %
25.16 %
25.87 %
26.26 %
27.29 %
27.25 %
27.00 %
28.20 %
28.62 %
29.14 %
27.68 %
27.53 %
DIIs
14.90 %
15.74 %
21.40 %
22.29 %
24.78 %
25.19 %
34.78 %
33.91 %
34.35 %
34.53 %
35.05 %
33.98 %
33.66 %
35.32 %
35.69 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
28.99 %
28.17 %
23.83 %
23.29 %
23.07 %
21.96 %
11.99 %
11.84 %
11.48 %
11.57 %
9.91 %
10.57 %
10.38 %
10.19 %
9.97 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,780.00 4,25,929.94 38.00 49,887.17 12.06 9,648 27.35 40.93
1,465.50 1,18,825.56 25.74 26,520.66 14.17 4,155 12.95 37.73
2,558.65 1,02,885.42 48.65 10,615.63 19.57 1,942 28.89 45.52
1,195.35 1,01,290.13 18.97 28,905.40 12.36 5,578 -9.47 29.85
944.05 95,280.30 22.27 19,831.50 13.82 3,831 14.57 31.20
2,043.00 92,929.19 35.38 20,141.50 19.94 1,936 73.52 37.89
1,220.00 73,119.28 20.05 29,559.25 17.55 3,169 8.65 18.05
5,604.75 66,062.65 30.38 12,978.42 9.84 1,811 14.16 40.42
1,466.40 42,112.35 - 12,653.09 6.58 -1,831 675.84 28.12
1,573.55 39,910.21 59.43 7,829.81 22.92 529 80.05 52.22

Corporate Action

Technical Indicators

RSI(14)
Neutral
29.85
ATR(14)
Less Volatile
35.94
STOCH(9,6)
Neutral
25.70
STOCH RSI(14)
Oversold
17.26
MACD(12,26)
Bearish
-7.86
ADX(14)
Strong Trend
34.62
UO(9)
Bearish
47.63
ROC(12)
Downtrend And Accelerating
-5.10
WillR(14)
Oversold
-83.42